Tolerance and pharmacokinetics of PEG-INF-SA in healthly volunteers: Randomized, Single center, Dose-ranging, Open-Label study.

Trial Profile

Tolerance and pharmacokinetics of PEG-INF-SA in healthly volunteers: Randomized, Single center, Dose-ranging, Open-Label study.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jul 2013

At a glance

  • Drugs Peginterferon SA (Primary)
  • Indications Hepatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 15 Nov 2011 Actual initiation date changed from Nov 2010 to Oct 2010 as reported by Chinese Clinical Trial Register record.
    • 30 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top